Onderzoeker
Jens De Vos
- Trefwoorden:Geneeskunde, Toegepaste biologische wetenschappen
- Disciplines:Landbouwwetenschappen, diergeneeskunde en levensmiddelenwetenschappen
Affiliaties
- Medische Beeldvorming (Onderzoeksgroep)
Lid
Vanaf1 jan 2011 → Heden - Cellulaire en Moleculaire Immunologie (Onderzoeksgroep)
Lid
Vanaf1 okt 2009 → Heden - Faculteit van de Wetenschappen (Faculteit)
Lid
Vanaf22 jun 2017 → 7 sep 2017 - Ondersteunende Klinische wetenschappen (Departement)
Lid
Vanaf1 dec 2016 → 30 nov 2020 - Ondersteunende Klinische wetenschappen (Departement)
Lid
Vanaf1 okt 2014 → 30 nov 2020 - Toegepaste Biologische Wetenschappen (Departement)
Lid
Vanaf1 okt 2010 → 30 sep 2014 - Faculteit van de Wetenschappen (Faculteit)
Lid
Vanaf16 aug 2008 → 2 jul 2010
Publicaties
1 - 10 van 13
- Phase I trial of 131I-GMIB-Anti-HER2-VHH1, a new promising candidate for HER2-targeted radionuclide therapy in breast cancer patients(2021)
Auteurs: Matthias D'Huyvetter, Jens De Vos, Vicky Caveliers, Ilse Vaneycken, Johannes Heemskerk, Francois P Duhoux, Christel Fontaine, Marian Vanhoeij, Albert D Windhorst, Frank Van Der Aa, et al.
Pagina's: 1097-1105 - A nanobody-based tracer targeting DPP6 for non-invasive imaging of human pancreatic endocrine cells(2017)
Auteurs: Alexander Balhuizen, Sam Massa, Iris Mathijs, Jean-Valery Turatsinze, Jens De Vos, Stéphane Demine, Catarina Xavier, Olatz Villate, Isabelle Millard, Dominique Egrise, et al.
Pagina's: 15130 - I-131-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment(2017)
Auteurs: Matthias D'Huyvetter, Jens De Vos, Catarina Xavier, Marek Pruszynski, Yann G J Sterckx, Sam Massa, Geert Raes, Vicky Caveliers, Michael R Zalutsky, Tony Lahoutte, et al.
Pagina's: 6616-6628 - Site-specific labeling of cysteine-tagged camelid single-domain antibody-fragments for use in molecular imaging(2014)
Auteurs: Sam Massa, Catarina Xavier, Jens De Vos
Pagina's: 979-988 - Specific Targeting of Atherosclerotic Plaques in ApoE(-/-) Mice Using a New Camelid sdAb Binding the Vulnerable Plaque Marker LOX-1.(2014)
Auteurs: Jens De Vos, Iris Mathijs, Catarina Xavier, Sam Massa, Ulrich Wernery
Pagina's: 690-698 - Camelid single-domain antibody-fragment engineering for (pre)clinical in vivo molecular imaging applications: Adjusting the bullet to its target(2013)
Auteurs: Jens De Vos
Pagina's: 1149-1160 - Nanobodies Targeted Mouse/Human VCAM1 for the Nuclear Imaging of Atherosclerotic Lesions(2012)Volume: 14
Auteurs: Alexis Broisat, Jakub Toczek, Jens De Vos, Laurent M. Riou, Sandrine Martin, Mitra Ahmadi, Daniel Fagret, Catherine Ghezzi
- Site-specific labeling of his-tagged Nanobodies with 99mTc: A practical guide(2012)Series: Methods in Molecular Biology
Auteurs: Catarina Xavier, Ilse Vaneycken, Jens De Vos, Sam Massa
Pagina's: 485-490Aantal pagina's: 6 - Molecular Imaging using Nanobodies: a case study(2012)Series: Methods in Molecular Biology
Auteurs: Catarina Xavier, Ilse Vaneycken, Jens De Vos, Sam Massa
Pagina's: 559-567Aantal pagina's: 9 - Development of LOX-1 Nanobodies for in vivo imaging of atherosclerosis(2012)
Auteurs: Jens De Vos, Jakub Toczek, Catherine Ghezzi
Patenten
1 - 6 van 6
- Anti-macrophage mannose receptor single variable domains for use in cardiovascular diseases (Inventor)
- Radio-labelled antibody fragments for use in the prevention and/or treatment of cancer (Inventor)
- Method of imaging a cardiovascular disease with an anti-macrophage mannose receptor immunoglobulin single variable domain (Inventor)
- Radiolabelled antibody fragments for use in treating cancer (Inventor)
- Radiolabelled antibody fragments for use in treating cancer (Inventor)
- Radiolabelled antibody fragments for use in treating cancer (Inventor)